Calendar

May 2012
SunMonTueWedThuFriSat
 << < > >>
  12345
6789101112
13141516171819
20212223242526
2728293031  

Announce

Who's Online?

Member: 0
Visitor: 1

rss Syndication

Archives

Mar032012

Introduction to AUY922 Inhibitors
AUY922y may guide tumour cells survive in hostile microenvironments and Doramapimodstand internal mutations, so driving tumour growth. Inhibiting such Doramapimod may well AUY922refore inhibit growth in a wide range of tumour types.Over-expressed Doramapi


Admin · 3 views · Leave a comment
Feb272012

Introduction to Everolimus Inhibitors
For the therapy with patients with solid tumors (ovary, breast, and NSCLC), courses of TAXOL should not be repeated until the neutrophil count is at least 1500 cells/mm3 and the platelet count is at the least 100, 000 cells/mm3. TAXOL really given to pati


Admin · 57 views · Leave a comment
Feb272012

Introduction to Compound Libraries Inhibitor
Lapatinib may change the best way your heart beats together with pumps blood through your body. Your doctor will monitor you carefully to see whether lapatinib has affected your heart. Talk for your doctor about the risks of taking Lapatinib inhibitor in


Admin · 82 views · Leave a comment
Feb252012

Knowledge about AUY922 Inhibitor
This is the first molecule arising using an original research collaboration between Vernalis and Novartis, were only available in 2004, to enter scientific testing. Hsp90 inhibitors such since AUY922 have the potential to be effective against a range of c


Admin · 21 views · Leave a comment
Feb242012

Knowledge about Tivozanib Signaling Pathways
A great development in neuro-scientific biotech and pharmaceutics has been witnessed lately and this huge progress has altered the lives of many for good. The rate of development is indeed pronounced that every some other minute something better is being


Admin · 25 views · Leave a comment

1, 2, 3  Next page